$420 Million is the total value of Sio Capital Management, LLC's 69 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 212.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ITCI | New | INTRA-CELLULAR THERAPIES INCput | $66,795,000 | – | 1,946,800 | +100.0% | 15.91% | – |
GWPH | Buy | GW PHARMACEUTICALS PLCads | $19,423,000 | -6.0% | 185,757 | +3.4% | 4.63% | -30.5% |
CHRS | Buy | COHERUS BIOSCIENCES INC | $17,046,000 | +39.1% | 946,761 | +56.5% | 4.06% | +2.9% |
MDT | Buy | MEDTRONIC PLC | $16,680,000 | +90.3% | 147,022 | +82.2% | 3.97% | +40.7% |
MRK | New | MERCK & CO INC | $15,439,000 | – | 169,755 | +100.0% | 3.68% | – |
PFE | Buy | PFIZER INC | $14,923,000 | +45.0% | 380,874 | +33.0% | 3.55% | +7.2% |
CVM | Buy | CEL-SCI CORPput | $13,978,000 | +124.8% | 1,527,600 | +119.6% | 3.33% | +66.2% |
GILD | New | GILEAD SCIENCES INC | $12,086,000 | – | 186,000 | +100.0% | 2.88% | – |
UTHR | Buy | UNITED THERAPEUTICS CORP | $11,685,000 | +67.1% | 132,664 | +51.3% | 2.78% | +23.6% |
MOH | Buy | MOLINA HEALTHCARE INC | $9,937,000 | +178.7% | 73,236 | +125.4% | 2.37% | +106.2% |
GSK | New | GLAXOSMITHKLINE PLCsponsored adr | $9,619,000 | – | 204,705 | +100.0% | 2.29% | – |
MCK | Buy | MCKESSON CORP | $9,466,000 | +9.6% | 68,439 | +8.3% | 2.26% | -18.9% |
ABC | Buy | AMERISOURCEBERGEN CORP | $9,458,000 | +11.4% | 111,249 | +7.9% | 2.25% | -17.6% |
ANTM | Buy | ANTHEM INC | $9,284,000 | +41.7% | 30,739 | +12.7% | 2.21% | +4.8% |
SNY | New | SANOFI SAsponsored adr | $8,583,000 | – | 170,977 | +100.0% | 2.04% | – |
MEIP | Buy | MEI PHARMA INC | $5,949,000 | +1267.6% | 2,398,852 | +826.7% | 1.42% | +912.1% |
IMVT | New | IMMUNOVANT INC*w exp 12/18/2024 | $5,483,000 | – | 615,400 | +100.0% | 1.31% | – |
MMSI | New | MERIT MEDICAL SYSTEMS INC | $4,683,000 | – | 150,000 | +100.0% | 1.12% | – |
ARDX | New | ARDELYX INC | $4,665,000 | – | 621,534 | +100.0% | 1.11% | – |
ARNA | Buy | ARENA PHARMACEUTICALS INC | $4,059,000 | +102.2% | 89,357 | +103.7% | 0.97% | +49.7% |
ESPR | New | ESPERION THERAPEUTICS INC | $3,379,000 | – | 56,658 | +100.0% | 0.80% | – |
SYRS | New | SYROS PHARMACEUTICALS INC | $3,099,000 | – | 448,532 | +100.0% | 0.74% | – |
SAGE | New | SAGE THERAPEUTICS INCput | $3,025,000 | – | 41,900 | +100.0% | 0.72% | – |
New | TRILLIUM THERAPEUTICS INC | $2,834,000 | – | 2,751,186 | +100.0% | 0.68% | – | |
AFMD | New | AFFIMED NV | $2,790,000 | – | 1,018,200 | +100.0% | 0.66% | – |
HROW | Buy | HARROW HEALTH INC | $2,684,000 | +41.0% | 344,940 | +1.9% | 0.64% | +4.2% |
PFNX | Buy | PFENEX INC | $2,554,000 | +56.3% | 232,626 | +20.2% | 0.61% | +15.6% |
ZFGN | New | ZAFGEN INC | $2,534,000 | – | 2,283,164 | +100.0% | 0.60% | – |
ASLN | New | ASLAN PHARMACEUTICALS LTDads | $2,066,000 | – | 1,017,971 | +100.0% | 0.49% | – |
RDUS | New | RADIUS HEALTH INC | $2,016,000 | – | 100,000 | +100.0% | 0.48% | – |
WVE | New | WAVE LIFE SCIENCES LTDcall | $1,756,000 | – | 219,100 | +100.0% | 0.42% | – |
PHG | New | KONINKLIJKE PHILIPS NVput | $1,649,000 | – | 33,800 | +100.0% | 0.39% | – |
ARAV | New | ARAVIVE INC | $1,342,000 | – | 98,201 | +100.0% | 0.32% | – |
BCEL | New | ATRECA INC | $1,320,000 | – | 85,312 | +100.0% | 0.31% | – |
BEAT | New | BIOTELEMETRY INCput | $1,306,000 | – | 28,200 | +100.0% | 0.31% | – |
PGNY | New | PROGYNY INC | $1,233,000 | – | 44,910 | +100.0% | 0.29% | – |
ARVN | New | ARVINAS INC | $1,235,000 | – | 30,052 | +100.0% | 0.29% | – |
OPK | New | OPKO HEALTH INC | $1,184,000 | – | 805,311 | +100.0% | 0.28% | – |
SPPI | Buy | SPECTRUM PHARMACEUTICALS INCcall | $1,133,000 | -53.3% | 311,400 | +6.4% | 0.27% | -65.5% |
OVID | New | OVID THERAPEUTICS INC | $1,098,000 | – | 264,581 | +100.0% | 0.26% | – |
NLTX | New | NEOLEUKIN THERAPEUTICS INC | $1,086,000 | – | 88,185 | +100.0% | 0.26% | – |
MRSN | New | MERSANA THERAPEUTICS INC | $953,000 | – | 166,250 | +100.0% | 0.23% | – |
ABEO | New | ABEONA THERAPEUTICS INC | $924,000 | – | 282,520 | +100.0% | 0.22% | – |
LOGC | Buy | LOGICBIO THERAPEUTICS INC | $906,000 | -31.6% | 125,836 | +2.7% | 0.22% | -49.4% |
KRTX | New | KARUNA THERAPEUTICS INC | $722,000 | – | 9,588 | +100.0% | 0.17% | – |
DTIL | New | PRECISION BIOSCIENCES INC | $603,000 | – | 43,433 | +100.0% | 0.14% | – |
LPTX | New | LEAP THERAPEUTICS INC | $533,000 | – | 476,223 | +100.0% | 0.13% | – |
CMD | New | CANTEL MEDICAL CORPput | $518,000 | – | 7,300 | +100.0% | 0.12% | – |
MTD | New | METTLER-TOLEDO INTERNATIONAL INCput | $317,000 | – | 400 | +100.0% | 0.08% | – |
New | APTOSE BIOSCIENCES INC | $284,000 | – | 50,000 | +100.0% | 0.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
SANOFI SA | 19 | Q3 2022 | 9.8% |
MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
PFENEX ORD | 18 | Q4 2019 | 5.9% |
AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
SC 13G/A | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13G | 2024-02-14 |
13F-HR | 2024-02-13 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
SC 13G | 2023-02-13 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.